Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 10, 2006, Pages 1295-1304

  Lane, Majella E ^a   Kim, Mi Jeong ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROTEC; CALPROTECTIN; CIMETIDINE; CITRIC ACID; DICLOFENAC; DIPALMITOYLPHOSPHATIDYLCHOLINE; EDETIC ACID; FAMOTIDINE; FENBUFEN; FLURBIPROFEN; GLUCOSE; GLUTAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; METRONIDAZOLE; MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN DERIVATIVE; RIOPROSTIL; SALAZOSULFAPYRIDINE; SUCRALFATE;

CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG EXPOSURE; DRUG STRUCTURE; DYSPEPSIA; ENTERITIS; ENTEROPATHY; ENZYME INHIBITION; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL PAIN; GASTROINTESTINAL TOXICITY; GASTROINTESTINAL TRACT; HEARTBURN; HUMAN; HYPOALBUMINEMIA; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFORATION; IRON DEFICIENCY ANEMIA; NAUSEA; NONHUMAN; REVIEW; STOMACH ULCER; UPPER GASTROINTESTINAL BLEEDING; VOMITING;

EID: 33750050310     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2006.tb01645.x     Document Type: Review

References (92)

1. 51Cr-Ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand. J. Gastroenterol. 25: 917-924
2. Aabakken, L., Larsen, S., Osnes, M. (1989a) Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal anti-inflammatory drugs. Scand. J. Rheumatol. 18: 369-375
3. Aabakken, L., Larsen, S., Osnes, M. (1989b) Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract. Scand. J. Rheumatol. 18: 361-368
4. Aabakken, L., Bjørnbeth, B. A., Weberg, R., Vikmoen, L., Larsen, S., Osnes, M. (1990) NSAID-associated gastroduodenal damage: does famotidine protection extend into the mid and distal duodenum? Aliment. Pharmacol. Ther. 4: 295-303
5. Albert, A. (1958) Chemical aspects of selective toxicity. Nature 182: 421-423
6. Anand, B. S., Romero, J. J., Sanduja, S. K., Lichtenberger, L. M. (1999) Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am. J. Gastroenterol. 94: 1818-1822
7. Ann, J. Y., Kim, S. J., Han, S. P., Kim, J. W., Kim, H. J., Do, J. H., Kim, J. G., Chang, S. K., Jeon, W. K. (2004) Effect of glutamine on the non-steroidal anti-inflammatory drug-induced bacterial translocation. Korean J. Gastroenterol. 44: 252-258
8. Appleyard, M., Fireman, Z., Glukhovsky, A., Jacob, H., Shreiver, R., Kadirkamanathan, S., Lavy, A., Lewkowicz, S., Scapa, E., Shofti, R., Swain, P., Zaretsky, A. (2000) A randomized trial comparing wireless capsule endoscopy with push enteroscopy for the detection of small-bowel lesions. Gastroenterology 119: 1431-1438
9. Banerjee, A. K., Sherwood, R., Rennie, J. A., Peters, T. J. (1986) Sulphasalazine reduced indomethacin induced changes in small intestinal permeability in man. Br. Soc. Gastro. 23: A593
10. Barrachina, M. D., Panes, J., Esplugues, J. V. (2001) Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development. Curr. Pharm. Des. 7: 31-48
11. Basivireddy, J., Vasudevan, A., Jacob, M., Balasubramanian, K. A. (2002) Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes. Biochem. Pharmacol. 64: 339-349
12. Basivireddy, J., Jacob, M., Balasubramanian, K. A. (2004) Oral glutamine attenuates indomethacin-induced small intestinal damage. Clin. Sci. (Lond). 107: 281-289
13. Berggren, S., Hoogstraate, J., Fagerholm, U., Lennernäs, H. (2003) Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. Eur. J. Pharm. Sci. 21: 553-560
14. Bjarnason, I., Hayllar, J. (1996) Early pathogenic events in NSAID-induced gastrointestinal damage. Ital. J. Gastroenterol. Hepatol. 28 (Suppl. 4): 19-22
15. Bjarnason, I., Macpherson, A. J. (1994) Intestinal toxicity of non-steroidal anti-inflammatory drugs. Pharmacol. Ther. 62: 145-157
16. Bjarnason, I., Thjodleifsson, B. (1999) Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology 38 (Suppl. 1): 24-32
17. Bjarnason, I., O'Morain, C., Levi, A. J., Peters, T. J. (1983) Absorption of 51 chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 85: 318-322
18. Bjarnason, I., Williams, P., So, A., Zanelli, G. D., Levi, A. J., Gumpel, J. M., Peters, T. J., Ansell, B. (1984) Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet ii: 1171-1174
19. Bjarnason, I., Peters, T. J., Levi, A. J. (1986a) Intestinal permeability: clinical correlates. Dig. Dis. 4: 83-92
20. Bjarnason, I., Williams, P., Smethurst, P., Peters, T. J., Levi, A. J. (1986b) Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 27: 1292-1297
21. Bjarnason, I., Zanelli, G., Smith, T. (1987) Nonsteroidal anti-inflammatory drug induced intestinal inflammation in humans. Gastroenterology 93: 480-489
22. Bjarnason, I., Price, A. B., Zanelli, G., Smethurst, P., Burke, M., Gumpel, J. M., Levi, A. J. (1988) Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology 94: 1070-1074
23. Bjarnason, I., Smethurst, P., Clark, P., Menzies, I., Levi, J., Peters, T. (1989a) Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man. Scand. J. Gastroenterol. (Suppl.) 164: 97-102
24. Bjarnason, I., Smethurst, P., Fenn, C. G., Lee, C. E., Menzies, I. S., Levi, A. J. (1989b) Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig. Dis. Sci. 34: 407-411
25. Bjarnason, I., Fehilly, B., Smethurst, P., Menzies, I. S., Levi, A. J. (1991) The importance of local versus systemic effects of non-steroidal anti-inflammatory drugs to increase intestinal permeability in man. Gut 32: 275-277
26. Bjarnason, I., Hayllar, J., Smethurst, P., Price, A., Gumpel, M. J. (1992a) Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy Gut 33: 1204-1208
27. Bjarnason, I., Smethurst, P., Macpherson, A., Walker, F., McElnay, J. C., Passmore, P., Menzies, I. S. (1992b) Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 102: 1546-1550
28. Bjarnason, I., Hayllar, J., Macpherson, A. J., Russell, A. S. (1993a) Side-effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832-1847
29. Bjarnason, I., Macpherson, A., Somasundaram, S., Teahon, K. (1993b) Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease. Can. J. Gastroenterol. 7: 160-169
30. Brookes, P. M., Day, R. O. (1991) Nonsteroidal antiinflammatory drugs: differences and similarities. N. Engl. J. Med. 324: 1716-1725
31. Brune, K., Schwietzer, A., Eckert, H. (1977) Parietal cells of the stomach trap salicylates during absorption. Biochem. Pharmacol. 26: 1735-1740
32. Butler, B. D., Lichtenberger, L. M., Hills, B. A. (1983) Distribution of surfactants in the canine GI tract and their ability to lubricate. Am. J. Physiol. 7: G645-G651
33. Chadwick, V. S., Phillips, S. F., Hofmann, A. F. (1977) Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology 73: 241-246
34. Cronstein, B. N., Naime, D., Ostad, E. (1993) The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92: 2675-2682
35. Davies, N. M., Jamali, F. (1997) Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. Hum. Exp. Toxicol. 16: 345-349
36. Davies, G. R., Wilkie, M. E., Rampton, D. S. (1993) Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig. Dis. Sci. 38: 417-425
37. Davies, N. M., Roseth, A. G., Appleyard, C. B., McKnight, W., Del Soldato, P., Calignano, A., Cirino, G., Wallace, J. L. (1997) NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment. Pharmacol. Ther. 11: 69-79
38. Fagerholm, U., Bjornsson, M. A. (2005) Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582. J. Pharm. Pharmacol. 57: 1539-1554
39. Fitzgerald, G. A. (2004) Coxibs and cardiovascular disease. N. Engl. J. Med. 351: 1709-1711
40. Giraud, M. -N., Motta, C., Romero, J. J., Bommelaer, G., Lichtenberger, L. M. (1999) Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem. Pharm. 5: 247-254
41. Graham, D. Y., Agrawal, N. M., Roth, S. H. (1988) Prevention of NSAID-induced gastric ulcer with misoprostol: multi-centre, double-blind, placebo-controlled trial. Lancet ii: 1277-1280
42. Graham, D. Y., White, R. H., Moreland, L. W., Schubert, T. T., Katz, R., Jaszewski, R., Tindall, E., Triadafilopoulos, G., Stromatt, S. C., Teoh, L. S. (1993) Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann. Intern. Med. 119: 257-262
43. Gullikson, G. W., Cline, W. S., Lorenzson, V., Benz, L., Olsen, W. A., Bass, P. (1977) Effects of anionic surfactants on hamster small intestinal membrane structure and functions; relationship to surface activity. Gastroenterology 73: 501-511
44. Gullikson, G. W., Sender, M., Bass, P. (1981) Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J. Pharmacol. Exp. Ther. 220: 236-252
45. Hawkey, C. J., Jones, J. I., Atherton, C. T., Skelly, M. M., Bebb, J. R., Fagerholm, U., Jonzon, B., Karlsson, P., Bjarnason, I. T. (2003) Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut 52: 1537-1542
46. Hayashi, Y., Yamamoto, H., Kita, H., Sunada, K., Sato, H., Yano, T., Iwamoto, M., Sekine, Y., Miyata, T., Kuno, A., Iwaki, T., Kawamura, Y., Ajibe, H., Ido, K., Sugano, K. (2005) Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J. Gastroenterol. 11: 4861-4864
47. Herschman, H. R. (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13: 241-256
48. Hills, B. A., Butler, B. D., Lichtenberger, L. M. (1983) Gastric mucosal barrier: the hydrophobic lining to the lumen of the stomach. Am. J. Physiol. 7: G561-G568
49. Hond, E. D., Peeters, M., Hiele, M., Bulteel, V., Ghoos, Y., Rutgeerts, P. (1999) Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Aliment. Pharmacol. Ther. 13: 679-685
50. Hudson, N., Hawkey, C. J. (1993) Non-steroidal anti-inflammatory drug associated upper gastrointestinal ulceration and complications. Eur. J. Gastroenterol. Hepatol. 5: 412-419
51. Iddan, G., Meron, G., Glukhovsky, A., Swain, P. (2000) Wireless capsule endoscopy. Nature 405: 417
52. 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am. J. Gastroenterol. 82: 1159-1164
53. Khazaeinia, T., Jamalia, F. A. (2003) Comparison of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt. J. Pharm. Pharm. Sci. 6: 352-359
54. Khazaeinia, T., Jamali, F. (2004) Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat. Inflammopharmacology 12: 69-80
55. Komiya, I., Park, J. Y., Kamani, A., Ho, N. H. F., Higuchi, W. I. (1980) Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 4: 249-262
56. Lane, M. E., O'Driscoll, C. M., Corrigan, O. I. (1996) The relationship between rat intestinal permeability and hydrophilic probe size. Pharm. Res. 13: 1554-1558
57. Lane, M. E., Levis, K., McDonald, G. S., Corrigan, O. I. (2006) Comparative assessment of two indices of drug induced permeability changes in the perfused rat intestine. Int. J. Pharm. 312: 196-199
58. Larkai, E. N., Smith, J. L., Lidsky, M. D., Graham, D. Y. (1997) Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am. J. Gastroenterol. 92: 363-364
59. Legen, I., Kristl, A. (2002) Ketoprofen-induced intestinal permeability changes studied in side-by-side diffusion cells. J. Pharm. Pharmacol. 54: 1419-1422
60. Levi, S., de Lacey, G., Price, A. B., Gumpel, M. J., Levi, A. J., Bjarnason, I. (1990) 'Diaphragm-like' strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br. J. Radiol. 63: 186-189
61. Lichtenberger, L. M. (1995) The hydrophobic barrier of gastrointestinal mucus. Annu. Rev. Physiol. 57: 565-583
62. Lichtenberger, L. M., Graziani, L. A., Dial, E. J., Butler, B. D., Hills, B. A. (1983) Role of surface-active phospholipids in gastric cytoprotection. Science 219: 1327-1329
63. Lichtenberger, L. M., Romero, J. J., Wang, Z. M. (1994) ASA form an ionic complex with phosphatidyl choline: possible molecular explanation for its ulcerogenic action. Gastroenterology 106: A134
64. Lichtenberger, L. M. Wang, Z. -M., Romero J. J., Ulloa, C., Perez, J. C., Giraud, M. N., Barreto, J. C. (1995) Nonsteroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat. Med. 1: 154-158
65. Lichtenberger, L. M., Ulloa, C., Vanous, A. L., Illich, P. A., Dial, E. J. (1996) NSAID and phospholipid prodrugs: combination therapy with antisecretory agents. Gastroenterology 11: 990-995
66. Lugea, A., Antolin, M., Mourelle, M., Guraner, F., Malagelada, J. R. (1997) Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. Gastroenterology 112: 1931-1939
67. Mahmud, T., Rafi, S. S., Scott, D. L., Wrigglesworth, J. M., Bjarnason, I. (1996) Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum. 39; 1998-2003
68. Meling, T. R., Aabakken, L., Roseth, A., Osnes, M. (1996) Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand. J. Gastroeneterol. 31: 339-344
69. Menzies, I. S. (1984) Transmucosal passage of inert molecules in health and disease. In: Skadhauge, E., Heintze, K. (eds) Intestinal absorption and secretion. Falk Symposium 36. Lancaster MTP Press, Lancaster, pp 527-543
70. Miglioli, M., Porro, G. B., Vaira, D., Menegatti, M., Brunetti, G., Petrillo, M., Ardizzone, S., Frizziero, L., Montrone, F., Grandinetti, G. (1996) Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Am. J. Gastroenterol. 91: 2367-2371
71. Morris, A. J., Madhok, R., Sturrock, R. D., Capell, H. A., MacKenzie, J. F. (1991) Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs. Lancet 337: 520
72. Morris, A. J., Wasson, L. A., Mackenzie, J. F. (1992) Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33: 887-889
73. Muscara, M. N., Wallace, J. L. (1999) Nitric oxide. V. Therapeutic potential of nitric oxide donors and inhibitors. Am. J. Physiol. 276: G1313-G1316
74. Pain Therapeutics (2005) In: Pain therapeutics 2005: market dynamics and outlook. Arrowhead Publishers, MN
75. Pierpont, W. S. (1997) The natural history of salicylic acid, plant product and mammalian medicine. Interdiscip. Sci. Rev. 22: 45-52
76. Pooley, N., Ghosh, L., Sharon, P. (1995) Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 40: 219-225
77. Reuter, B. K., Davies, N. M., Wallace, J. L. (1997) Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112: 109-117
78. 111In granulocyte scanning. Br. Med. J. (Clin. Res. Ed.) 287: 1751-1753
79. 111Indium autologous leucocytes in inflammatory bowel disease. Gut 24: 293-299
80. Somasundaram, S., Rafi, S., Jacob, M., Sigthorsson, G., Mahmud, T., Sherwood, R., Price, A. B., Macpherson, A., Scott, D., Wrigglesworth, J. M., Bjarnason, I. (1997a) Intestinal tolerability of nitroxybutyl-flurbiprofen in rats. Gut 40: 608-613
81. Somasundaram, S., Rafi, S., Hayllar, J., Sigthorsson, G., Jacob, M., Price, A. B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J. M., Bjarnason, I. (1997b) Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 41: 344-353
82. Somasundaram, S., Simpson, R., Rafi, S., Shergill, J. K., Bjarnason, I., Wrigglesworth, J. (2002) 2,4-Diamino-6-hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum. BMC Gastroenterol. 2: 8
83. Tang, A. S., Chikhale, P. J., Shah, P. K., Borchardt, R. T. (1993) Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents. Pharm. Res. 10: 1620-1626
84. Tibble, J. A., Sigthorsson, G., Foster, R., Scott, D., Fagerhol, M. K., Roseth, A., Bjarnason, I. (1999) High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45: 362-366
85. Vaananen, P. M., Meddings, J. B., Wallace, J. L. (1991) Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am. J. Physiol. 261: G470-G475
86. Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231: 232-235
87. Wallace, J. (1996) Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide. Clin. Invest. Med. 19: 346-351
88. Wallace, J. L., Miller, M. J. (2000) Nitric oxide in mucosal defence: a little goes a long way. Gastroenterology 119: 512-520
89. Wallace, J. L., Reuter, B., Cicala, C., McKnight, W., Grisham, M. B., Cirino, G. (1994) Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107: 173-179
90. Washington, N., Washington, C., Wilson, C. G. (2001) Physiological pharmaceutics. Taylor and Francis, London
91. Yamamoto, H., Kita, H., Sunada, K., Hayashi, Y., Sato, H., Yano, T., Iwamoto, M., Sekine, Y., Miyata, T., Kuno, A., Ajibe, H., Ido, K., Sugano, K. (2004) Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin. Gastroenterol. Hepatol. 2: 1010-1016
92. Zalev, A. H., Gardiner, G. W., Warren, R. E. (1998) NSAID injury to the small intestine. Abdom. Imaging 23: 40-44